Integrative Bioinformatics Approach to Identify Prognostic Gene Signatures for Risk Stratification in Thyroid Carcinoma
Abstract
Thyroid cancer is a heterogeneous malignancy with variable outcomes, highlighting the need for reliable biomarkers and effective risk stratification. In this study, we implemented a multi-step integrative framework to identify distinct prognostic biomarker sets using transcriptomic data from 572 thyroid cancer patients. Correlation analysis followed by false discovery rate (FDR) correction revealed significant associations of genes. Notably, MAFF (r = 0.25, p = 1.34x10-, FDR = 2.46x10-), NR4A3 (r = 0.24, p = 1.26x10-, FDR = 9.25x10-), and SRF showed strong positive correlations, whereas LOC728264 (r = -0.21, p = 7.39x10-, FDR = 6.36x10-) and VAMP1 (r = -0.20, p = 1.20x10-, FDR = 1.3x10-) exhibited negative correlations with OS. Univariate Cox regression identified several survival-associated genes, including TMEM90B (HR = 10.66, p = 2.88x10-) and PTH1R (HR = 9.88, p = 5.55x10-). LASSO regression further identified 31 key prognostic genes, including 13 potential drug targets predominantly functioning as inhibitors. Machine learning models based on seven independent 20-gene biomarker sets effectively predicted Class 0 (0-1 years), Class 1 (1-3 years), Class 2 (3-5 years), and Class 3 (>5 years), achieving AUC values of 0.91-0.94 and Kappa up to 0.76. An ensemble model further improved prediction (AUC = 0.95, Kappa = 0.72). Incorporating clinical variables (age, gender, stage) enhanced model performance (AUC = 0.96, Kappa = 0.80). Reduced 10- and 5-gene subsets demonstrated consistent yet slightly lower performance (AUC = 0.90 and 0.86, respectively). Collectively, the 20-gene set exhibited the strongest predictive and prognostic potential, highlighting the importance of integrating molecular and clinical features for risk stratification in thyroid cancer.All data and code are openly available (https://github.com/raghavagps/THCA_prognostic_biomarkers), supporting future research in thyroid cancer prediction.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prognostic Biomarkers for Predicting Papillary Thyroid Carcinoma Patients at High Risk Using Nine Genes of Apoptotic Pathway
Chakit Arora, Dilraj Kaur, … Gajendra P. S. Raghava·PLoS ONEPeer-reviewed·Nov 12, 2021
- Multi-omics clustering analysis carries out the molecular specific subtypes of thyroid carcinoma: implicating for the precise treatment strategies
Zhenglin Wang, Qijun Han, … Wei Chen·Genes and ImmunityPeer-reviewed·Mar 4, 2025
- Integrated Multi-Omics Analysis for the Identification of Disease-Associated Variations and Prognostic Biomarkers in Triple-Negative Breast Cancer (TNBC)
NAGENDRA MANNEKUNTA, Elamathi Natarajan·bioRxiv·May 29, 2026
- Systematic Meta-Analysis of Published Transcriptomic Prognostic Signatures and Development of a Robust Multi-Cohort Prognostic Classifier for Triple-Negative Breast Cancer
Leepakshi Dhingra, Manulaya Singh, … Sherry Bhalla·bioRxiv·Jul 10, 2026
- LASSO Based Analysis for Prediction of Prognostic Signature Genes Associated with Breast Cancer
Souvik Guha, Soumita Seth, … Mohd Asif Shah·bioRxiv·Apr 2, 2024
- A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers
W. H. Chang, D. Forde, A. G. Lai·bioRxiv·Oct 14, 2018